Predictors of long-term clinical outcomes after TIPS: An ALTA group study.

IF 12.9 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Hepatology Pub Date : 2024-09-10 DOI:10.1097/hep.0000000000001091
Yael R Nobel,Justin R Boike,Nikhilesh R Mazumder,Bartley Thornburg,Rachel Hoffman,K Pallav Kolli,Michael Fallon,Jennifer C Lai,Giuseppi Morelli,Erin K Spengler,Adnan Said,Archita P Desai,Sonali Paul,Aparna Goel,Kelly Hu,Catherine Frenette,Dyanna Gregory,Cynthia Padilla,Yuan Zhang,Lisa B VanWagner,Elizabeth C Verna,
{"title":"Predictors of long-term clinical outcomes after TIPS: An ALTA group study.","authors":"Yael R Nobel,Justin R Boike,Nikhilesh R Mazumder,Bartley Thornburg,Rachel Hoffman,K Pallav Kolli,Michael Fallon,Jennifer C Lai,Giuseppi Morelli,Erin K Spengler,Adnan Said,Archita P Desai,Sonali Paul,Aparna Goel,Kelly Hu,Catherine Frenette,Dyanna Gregory,Cynthia Padilla,Yuan Zhang,Lisa B VanWagner,Elizabeth C Verna,","doi":"10.1097/hep.0000000000001091","DOIUrl":null,"url":null,"abstract":"BACKGROUND AND AIMS\r\nWhile transjugular intrahepatic portosystemic shunt (TIPS) is traditionally considered a bridge to liver transplant (LT), some patients achieve long-term transplant-free survival (TFS) with TIPS alone. Prognosis and need for LT should not only be assessed at time of procedure, but also re-evaluated in patients with favorable early outcomes.\r\n\r\nAPPROACH AND RESULTS\r\nAdult TIPS recipients in the multicenter Advancing Liver Therapeutic Approaches retrospective cohort study were included (N=1,127 patients; 2,040 person-years follow-up). Adjusted competing risk regressions were used to assess factors associated with long-term post-TIPS clinical outcomes at time of procedure and at 6 months post-TIPS. MELD-Na at TIPS was significantly associated with post-TIPS mortality (sHR of death 1.1 [p=0.42], 1.3 [p=0.04], and 1.7 [p<0.01] for MELD-Na 15-19, 20-24, and ≥25 relative to MELD-Na <15, respectively). MELD 3.0 was also associated with post-TIPS outcomes. Among the 694 (62%) patients who achieved early (6 mo) post-TIPS TFS, rates of long-term TFS were 88% at 1-year and 57% at 3-years post-TIPS. Additionally, a within-individual increase in MELD-Na score of >3 points from TIPS to 6 months post-TIPS was significantly associated with long-term mortality, regardless of initial MELD-Na score (sHR of death 1.8, p<0.01). For patients with long-term post-TIPS TFS, rates of complications of the TIPS or portal hypertension were low.\r\n\r\nCONCLUSIONS\r\nAmong patients with early post-TIPS TFS, prognosis and need for LT should be reassessed, informed by post-procedure changes in MELD-Na and clinical status. For selected patients, \"destination TIPS\" without LT may offer long-term survival with freedom from portal hypertensive complications.","PeriodicalId":177,"journal":{"name":"Hepatology","volume":null,"pages":null},"PeriodicalIF":12.9000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/hep.0000000000001091","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND AND AIMS While transjugular intrahepatic portosystemic shunt (TIPS) is traditionally considered a bridge to liver transplant (LT), some patients achieve long-term transplant-free survival (TFS) with TIPS alone. Prognosis and need for LT should not only be assessed at time of procedure, but also re-evaluated in patients with favorable early outcomes. APPROACH AND RESULTS Adult TIPS recipients in the multicenter Advancing Liver Therapeutic Approaches retrospective cohort study were included (N=1,127 patients; 2,040 person-years follow-up). Adjusted competing risk regressions were used to assess factors associated with long-term post-TIPS clinical outcomes at time of procedure and at 6 months post-TIPS. MELD-Na at TIPS was significantly associated with post-TIPS mortality (sHR of death 1.1 [p=0.42], 1.3 [p=0.04], and 1.7 [p<0.01] for MELD-Na 15-19, 20-24, and ≥25 relative to MELD-Na <15, respectively). MELD 3.0 was also associated with post-TIPS outcomes. Among the 694 (62%) patients who achieved early (6 mo) post-TIPS TFS, rates of long-term TFS were 88% at 1-year and 57% at 3-years post-TIPS. Additionally, a within-individual increase in MELD-Na score of >3 points from TIPS to 6 months post-TIPS was significantly associated with long-term mortality, regardless of initial MELD-Na score (sHR of death 1.8, p<0.01). For patients with long-term post-TIPS TFS, rates of complications of the TIPS or portal hypertension were low. CONCLUSIONS Among patients with early post-TIPS TFS, prognosis and need for LT should be reassessed, informed by post-procedure changes in MELD-Na and clinical status. For selected patients, "destination TIPS" without LT may offer long-term survival with freedom from portal hypertensive complications.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
TIPS 术后长期临床效果的预测因素:ALTA 小组研究。
背景和目的虽然经颈静脉肝内门体分流术(TIPS)传统上被认为是肝移植(LT)的桥梁,但有些患者仅靠 TIPS 就能实现长期无移植生存(TFS)。方法和结果纳入多中心推进肝脏治疗方法回顾性队列研究中的成人 TIPS 受者(N=1,127 例患者;2,040 人年随访)。采用调整后的竞争风险回归来评估手术时和手术后 6 个月时与 TIPS 术后长期临床结果相关的因素。TIPS时的MELD-Na与TIPS后死亡率显著相关(从TIPS到TIPS后6个月的死亡sHR分别为1.1[p=0.42]、1.3[p=0.04]和1.7[p3点],与长期死亡率显著相关,与初始MELD-Na评分无关(死亡sHR为1.8,p<0.01)。结论在 TIPS 术后早期 TFS 患者中,应根据术后 MELD-Na 和临床状态的变化重新评估预后和是否需要 LT。对于选定的患者,不进行 LT 的 "终点 TIPS "可提供长期生存,且不会出现门脉高压并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hepatology
Hepatology 医学-胃肠肝病学
CiteScore
27.50
自引率
3.70%
发文量
609
审稿时长
1 months
期刊介绍: HEPATOLOGY is recognized as the leading publication in the field of liver disease. It features original, peer-reviewed articles covering various aspects of liver structure, function, and disease. The journal's distinguished Editorial Board carefully selects the best articles each month, focusing on topics including immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases, liver cancer, and drug metabolism.
期刊最新文献
Prevalence of hepatitis C virus hypervariable region 1 insertions and their role in antibody evasion Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4 Drug treatments to prevent first decompensation in cirrhosis New ubiquitomic subtypes in hepatocellular carcinoma: Insights for future therapeutic approaches Role of microbiome in autoimmune liver diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1